Submandibular gland carcinoma; an audit of local control and survival following adjuvant radiotherapy

Oral Oncology

Volumn 35, Issue 2, 1999, Pages 187-190

  Sykes, A J ^a   Slevin, N J ^a   Birzgalis, A R ^a   Gupta, N K ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Carcinoma; Radiotherapy; Submandibular gland

Indexed keywords

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; BONE NECROSIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MALE; MEDICAL AUDIT; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; SALIVARY GLAND CARCINOMA; SUBMANDIBULAR GLAND; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOID CYSTIC; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; OSTEORADIONECROSIS; RADIOTHERAPY, ADJUVANT; SUBMANDIBULAR GLAND NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033036122     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00099-2     Document Type: Article

References (23)

1. Renehan A, Gleave EN, Hancock BD, Smith P, McGurk M. Long-term follow-up of over 1000 patients with salivary gland tumours treated in a single centre. Br J Surg 1996;83:1750-4.
2. In: TNM Atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. 3rd ed.: 2nd Revision, 1992.
3. Duthie MB, Gupta NK, Pointon RCS. In: Pointon RCS, editor, The radiotherapy of malignant disease. Berlin: Springer, 1991:145-206.
4. Peto R, Pike MC, Armitage P et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer 1976;34:585-612.
5. Andersen LJ, Therkildsen MH, Ockelmann HH, Bentzen JD, Schiodt T, Hansen HS. Malignant epithelial tumours in the minor salivary glands, the submandibular gland, and the sublingual gland. Prognostic factors and treatment results. Cancer 1991;68:2431-7.
6. Weber RS, Byers RM, Petit B, Wolf P, Ang K, Luna M. Submandibular gland tumours. Adverse histologic factors and therapeutic implications. Arch Otolaryngol Head Neck Surg 1990;116:1055-60.
7. Rafla S. Submaxillary gland tumours. Cancer 1970;26:821-826.
8. Byers RM, Jesse RH, Guillamondegui OM, Luna MA. Malignant tumours of the submaxillary gland. Am J Surg 1973; 126:458-63.
9. Bissett RJ, Fitzpatrick PJ. Malignant submandibular gland tumours. Am J Clin Oncol 1988;11:46-51.
10. Spiro RH, Huvos AG, Strong EW. Cancer of the parotid gland. A clinicopathologic study of 288 primary cases. Am J Surg 1975;130:452-9.
11. Ackerman LV, Rosai. In: Surgical pathology. St Louis, CV Mosby, 1974:515.
12. Simpson JR, Thawley SE, Matsuba HM. Adenoid cystic salivary gland carcinoma: treatment with irradiation and surgery. Radiology 1984;151:509-12.
13. Harrison LB, Armstrong JG, Spiro RH, Fass DE, Strong EW. Postoperative radiation therapy for major salivary gland malignancies. J Surg Oncol 1990;45:52-5.
14. McGregor GI, Robins RE. Submandibular and minor salivary gland carcinoma: A 15-year review. Am Surg 1977;43:737-42.
15. Sykes AJ, Logue JP, Slevin NJ, Gupta NK. An analysis of radiotherapy in the management of 104 patients with parotid carcinoma. Clin Oncol R Coll Radiol 1995;7:16-20.
16. Alinez F, Fletcher GH. Place and techniques of radiation therapy in the management of malignant tumours of the major salivary glands. Radiol 1965;34:412-19.
17. Frankenthaler RA, Luna MA, Lee SS, Ang KK, Byers RM, Guillamondegui OM Wolf P, Goepfert H. Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg 1991;117:1251-6.
18. de Haan LD, De Mullder PH, Vermorken JB, Schornagel JH, Vermey A, Verviej J. Cisplatin based chemotherapy in advanced adenoid cystic carcinoma of the head and neck. Head Neck 1992;14:273-7.
19. Hill ME, Constenla DO, A'Hern RP et al. Cisplatin and 5 fluouracil for symptom control in advanced salivary adenoid cystic carcinoma. Oral Oncol 1997;33:275-8.
20. Tsukuda M, Kotatsu T, Ito K, Mochimatsu I, Kubota A, Sawaki S. Chemotherapy for recurrent adeno and adenoid cystic carcinomas in the head and neck. J Cancer Res Clin Oncol 1993;119:756-8.
21. Airoldi M, Pedani F, Brando V, Gabriele P, Giordano C. Cisplatin, epirubicin and 5 fluouracil combination chemotherapy for recurrent carcinoma of the salivary gland. Tumori 1989;75:252-6.
22. Rowland KM, Taylor SG, Spiers AS et al. Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: An Eastern Co-operative Oncology Group pilot study. Cancer Treat Rep 1986;70:461-4.
23. Slevin NJ, Vasanthan S, Dougal MM. Relative clinical influence of tumour dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy. Int J Radiat Oncol Biol Phys 1993;25:23-8.